First Time Loading...

Edwards Lifesciences Corp
NYSE:EW

Watchlist Manager
Edwards Lifesciences Corp Logo
Edwards Lifesciences Corp
NYSE:EW
Watchlist
Price: 86.43 USD -1.8% Market Closed
Updated: Apr 29, 2024
EW
/
Income Statement
/
Revenue

Edwards Lifesciences Corp
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Edwards Lifesciences Corp
Revenue Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Edwards Lifesciences Corp
NYSE:EW
Revenue
$6B
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
11%
Becton Dickinson and Co
NYSE:BDX
Revenue
$19.5B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Revenue
$14.2B
CAGR 3-Years
13%
CAGR 5-Years
8%
CAGR 10-Years
7%
Stryker Corp
NYSE:SYK
Revenue
$20.5B
CAGR 3-Years
13%
CAGR 5-Years
9%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Revenue
$40.3B
CAGR 3-Years
3%
CAGR 5-Years
6%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Revenue
$7.3B
CAGR 3-Years
17%
CAGR 5-Years
14%
CAGR 10-Years
13%

Edwards Lifesciences Corp
Revenue Breakdown

Breakdown by Geography
Edwards Lifesciences Corp

Total Revenue: 6B USD
100%
United States: 3.5B USD
58.4%
Europe: 1.3B USD
22.2%
Rest Of World: 709.2m USD
11.8%
Japan: 452.4m USD
7.5%
Show More
Show Less

Breakdown by Segments
Edwards Lifesciences Corp

Total Revenue: 6B USD
100%
Transcatheter Aortic Valve Replacement: 3.9B USD
64.6%
Surgical Structural Heart: 999.3m USD
16.6%
Critical Care: 928.1m USD
15.5%
Transcatheter Mitral And Tricuspid Therapies: 197.6m USD
3.3%
Show More
Show Less

See Also

What is Edwards Lifesciences Corp's Revenue?
Revenue
6B USD

Based on the financial report for Dec 31, 2023, Edwards Lifesciences Corp's Revenue amounts to 6B USD.

What is Edwards Lifesciences Corp's Revenue growth rate?
Revenue CAGR 10Y
11%

Over the last year, the Revenue growth was 12%. The average annual Revenue growth rates for Edwards Lifesciences Corp have been 11% over the past three years , 10% over the past five years , and 11% over the past ten years .

ALPHA SPREAD
Join more than 132,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.